These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Long-term results of intraoperative presacral electron boost radiotherapy (IOERT) in combination with total mesorectal excision (TME) and chemoradiation in patients with locally advanced rectal cancer. Krempien R; Roeder F; Oertel S; Roebel M; Weitz J; Hensley FW; Timke C; Funk A; Bischof M; Zabel-Du Bois A; Niethammer AG; Eble MJ; Buchler MW; Treiber M; Debus J Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1143-51. PubMed ID: 16979835 [TBL] [Abstract][Full Text] [Related]
26. Electrocoagulation: an alternative treatment for rectal cancer. Tepetes K Tech Coloproctol; 2005 Jul; 9(2):172-3; author reply 173. PubMed ID: 16312027 [No Abstract] [Full Text] [Related]
27. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Vecchio FM; Valentini V; Minsky BD; Padula GD; Venkatraman ES; Balducci M; Miccichè F; Ricci R; Morganti AG; Gambacorta MA; Maurizi F; Coco C Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):752-60. PubMed ID: 15936556 [TBL] [Abstract][Full Text] [Related]
28. Local excision of stratified T1 rectal cancer. Wirsing K; Lorenzo-Rivero S; Luchtefeld M; Kim D; Monroe T; Attal H; Hoedema R Am J Surg; 2006 Mar; 191(3):410-2. PubMed ID: 16490557 [TBL] [Abstract][Full Text] [Related]
29. Gender differences in the treatment of rectal cancer: a population based study. Martling A; Granath F; Cedermark B; Johansson R; Holm T Eur J Surg Oncol; 2009 Apr; 35(4):427-33. PubMed ID: 18436417 [TBL] [Abstract][Full Text] [Related]
30. [A clinical study of therapy for local recurrent rectal cancer]. Noda K; Umekita N; Tanaka S; Ohkubo T; Inoue S; Kitamura M Gan To Kagaku Ryoho; 2006 Nov; 33(12):1830-3. PubMed ID: 17212120 [TBL] [Abstract][Full Text] [Related]
31. Is surgery-only the adequate treatment approach for T2N0 rectal cancer? Petersen S; Hellmich G; von Mildenstein K; Porse G; Ludwig K J Surg Oncol; 2006 Apr; 93(5):350-4. PubMed ID: 16550556 [TBL] [Abstract][Full Text] [Related]
32. Chemo-radiotherapy versus radiotherapy alone in the pre-operative treatment of resectable rectal cancer. Goethals L; Haustermans K; Perneel C; Bussels B; D'Hoore A; Geboes K; Ectors N; Van Cutsem E; Van den Bogaert W; Penninckx F Eur J Surg Oncol; 2005 Nov; 31(9):969-76. PubMed ID: 15936170 [TBL] [Abstract][Full Text] [Related]
33. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy. Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402 [TBL] [Abstract][Full Text] [Related]
34. Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival? Mawdsley S; Glynne-Jones R; Grainger J; Richman P; Makris A; Harrison M; Ashford R; Harrison RA; Osborne M; Livingstone JI; MacDonald P; Mitchell IC; Meyrick-Thomas J; Northover JM; Windsor A; Novell R; Wallace M Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):745-52. PubMed ID: 16199310 [TBL] [Abstract][Full Text] [Related]
35. [Long- term results after radical resection in patients with rectal cancer]. Wan DS; Ding PR; Wu XJ; Li LR; Pan ZZ; Zhou ZW; Lu ZH; Chen G Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Jul; 8(4):301-3. PubMed ID: 16167245 [TBL] [Abstract][Full Text] [Related]
36. Long-term results after neoadjuvant radiochemotherapy for locally advanced resectable extraperitoneal rectal cancer. Coco C; Valentini V; Manno A; Mattana C; Verbo A; Cellini N; Gambacorta MA; Covino M; Mantini G; Miccichè F; Pedretti G; Petito L; Rizzo G; Cosimelli M; Impiombato FA; Picciocchi A Dis Colon Rectum; 2006 Mar; 49(3):311-8. PubMed ID: 16456636 [TBL] [Abstract][Full Text] [Related]
37. Future directions in neoadjuvant therapy of rectal cancer: maximizing pathological complete response rates. Mohiuddin M; Mohiuddin MM; Marks J; Marks G Cancer Treat Rev; 2009 Nov; 35(7):547-52. PubMed ID: 19539429 [TBL] [Abstract][Full Text] [Related]